← FDA Drug Approvals (Drugs@FDA)

NADOLOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2018-06-01

Drug application

FDA Application #

ANDA210786

Application type

Abbreviated New Drug Application (Generic)

Brand name

NADOLOL

Generic name

Nadolol

Active ingredients

NADOLOL

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVAST LABS

First approval

2018-06-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown